Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Silver Castle Holdings Ltd. Share Issue/Capital Change 2022

Jan 12, 2022

7050_rns_2022-01-12_74ef9d61-a536-4674-952a-c3588c350a8a.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [112 x 87] intentionally omitted <==

January 12, 2022

403676

To: TASE Members

Dear Sir/Madam,

Re: ISRAEL CHINE BIOTECHNOLOGY (ICB) LTD

According to the company's report, dated January 12, 2022, a capital consolidation will be made in the Company's shares (IL0010970544), on January 19, 2022 to shareholders of record as of January 18, 2022. The capital consolidation will be made in a ratio of 10:1.

In accordance with the third part of TASE rules and regulations, there will be no trading in the company's shares on Wednesday, January 18, 2022, which is the record date for the capital consolidation.

Sincerely

(-)

Listing companies compliance unit

==> picture [385 x 58] intentionally omitted <==